Whole-genome sequencing revealed a novel structural variant in COL4A4 causing autosomal dominant Alport syndrome: A case report

Archive ouverte

Delage, Clément | Andreani, M. | Boukrout, Nihad | Sabaouni, Naoual | Perrais, Michael | Lefebvre, Bruno | Cauffiez, Christelle | Pottier, Nicolas | Larrue, Romain

Edité par CCSD -

International audience. Next-generation sequencing has substantially transformed the genomic diagnosis of individuals affected by inherited renal disorders. Indeed, accurate and rapid diagnostic for patients with suspected genetic kidney diseases is not only important for prognosis and patient management but also for family counseling. Alport syndrome, a genetic disease primarily affecting the basement membrane, is characterized by hematuria, progressive kidney failure, hearing impairment, as well as ocular abnormalities and stems from mutations in genes encoding type IV collagen. In this study, we show the benefit of whole-genome sequencing for the molecular diagnosis of a dominant form of Alport syndrome by identifying a novel heterozygous pathogenic structural variant in a family with three affected members. This case underscores the potential of whole-genome sequencing as a frontline diagnostic approach for inherited kidney diseases and further indicates that structural variations represent an important cause of monogenic disorders.

Suggestions

Du même auteur

Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity

Archive ouverte | Larrue, Romain | CCSD

International audience. Abstract Variability in genes involved in drug pharmacokinetics or drug response can be responsible for suboptimal treatment efficacy or predispose to adverse drug reactions. In addition to c...

Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity

Archive ouverte | Larrue, Romain | CCSD

International audience. Variability in genes involved in drug pharmacokinetics or drug response can be responsible for suboptimal treatment efficacy or predispose to adverse drug reactions. In addition to common gen...

miR-92a-3p regulates cisplatin-induced cancer cell death

Archive ouverte | Larrue, Romain | CCSD

International audience. Non-small cell lung cancer is characterized by a dismal prognosis largely owing to inefficient diagnosis and tenacious drug resistance. Therefore, the identification of new molecular determin...

Chargement des enrichissements...